Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1420 studies found for:    Open Studies | "Breast Neoplasms" AND "Breast Diseases"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Breast Neoplasms" AND "Breast Diseases" (1420 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Not yet recruiting Empowering Latinas to Obtain Breast Cancer Screenings
Conditions: Breastcancer;   Breast Diseases
Interventions: Behavioral: Empowerment;   Behavioral: Education
2 Recruiting Johns Hopkins Breast Cancer Program Longitudinal Repository
Conditions: Breast Cancer;   Benign Breast Disease
Intervention: Procedure: Sample collection
3 Recruiting Circadian Thermal Sensing to Detect Breast Disease
Condition: Early-Stage Breast Carcinoma
Intervention: Device: Cyrcadia CBR™ device placement for abnormality screening
4 Recruiting High-Intensity Interval Training for Women at Heightened Risk for Breast Cancer
Condition: Disorders of Breast
Interventions: Other: Exercise;   Behavioral: Questionnaires;   Behavioral: Motivational Session;   Behavioral: Phone Call;   Other: Printed Materials
5 Recruiting Does the Wording of Text Message Reminders Improve Uptake in Breast Screening?
Conditions: Breast Cancer;   Breast Disease
Interventions: Other: Intervention A - Behavioural Regulation;   Other: Intervention B - Priority
6 Recruiting Targeted Intraoperative Radiotherapy United States (TARGIT-US) Registry Trial
Conditions: Malignant Neoplasm of Breast;   Breast Diseases;   Ductal Breast Carcinoma
Intervention: Radiation: Intraoperative radiation therapy (IORT)
7 Not yet recruiting Cystic Breast Masses by Contrast Enhanced Ultrasound (CEUS)
Condition: Breast Cancer
Intervention: Drug: Definity
8 Not yet recruiting A Registry Study of Breast Microseed Treatment
Condition: Breast Neoplasms
Intervention: Radiation: Permanent Breast Seed Implant (PBSI)
9 Recruiting Phase 2 Study of Standard Chemotherapy With Trastuzumab, Plus or Minus Pertuzumab, for Pre-treated Metastatic Breast Cancer
Conditions: Breast Neoplasms;   Malignant Tumor of the Breast
Interventions: Drug: Trastuzumab;   Drug: Pertuzumab;   Drug: Vinorelbine, Paclitaxel, Nab-Paclitaxel , Docetaxel, Capecitabine
10 Not yet recruiting Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)
Conditions: Breast Neoplasm;   Breast Neoplasm, Male
Interventions: Drug: Cyclophosphamide;   Drug: Indomethacin;   Drug: Omeprazole;   Dietary Supplement: Multivitamin
11 Recruiting Chloroquine With Taxane Chemotherapy for Advanced or Metastatic Breast Cancer Patients Who Have Failed an Anthracycline (CAT)
Conditions: Breast Neoplasms;   Breast Cancer
Interventions: Drug: Taxane;   Drug: Taxotere;   Drug: Abraxane;   Drug: Ixabepilone
12 Recruiting Capecitabine Maintenance Therapy Following Capecitabine Combined With Docetaxel in Treatment of mBC
Conditions: Breast Neoplasms;   Neoplasms by Site;   Neoplasm Metastasis;   Breast Diseases;   Skin Diseases
Interventions: Drug: Docetaxel plus Capecitabine;   Drug: Capecitabine
13 Recruiting Window of Opportunity Trial of Dasatinib in Operable Triple Negative Breast Cancers With nEGFR
Conditions: Breast Neoplasms;   Triple Negative Breast Neoplasms
Interventions: Drug: Dasatinib;   Procedure: Conventional Surgery;   Other: Laboratory Biomarker Analysis
14 Recruiting Drug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With ER+ Breast Cancer
Conditions: Breast Cancer;   Estrogen Receptor Positive Breast Cancer
Interventions: Drug: entinostat;   Drug: exemestane
15 Recruiting Randomized Study of Combination Chemotherapy With or Without Focused Microwave Thermotherapy Before Surgery in Treating Women With Large Breast Cancer Tumors
Condition: Breast Cancer
Interventions: Device: Focused Microwave Thermotherapy;   Drug: Chemotherapy (control)
16 Recruiting Multimodality Breast Imaging for the Assessment of Tumor Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer Patients
Conditions: Breast Cancer;   Malignant Neoplasm of Breast
Interventions: Procedure: Dynamic Contrast Enhanced Molecular Resonance Imaging (DCE-MRI);   Procedure: Tc99m Sestamibi Molecular Breast Imaging (MBI);   Drug: 99mTc Sestamibi
17 Recruiting Neoadjuvant Letrozole Plus Metformin vs Letrozole Plus Placebo for ER-positive Postmenopausal Breast Cancer
Condition: Hormone Receptor Positive Malignant Neoplasm of Breast
Interventions: Drug: Metformin;   Drug: Placebo
18 Recruiting The Impact of the Oncotype DX® Breast Cancer Assay on Treatment Decisions in a Canadian Population
Condition: Hormone Receptor Positive Malignant Neoplasm of Breast
Intervention: Other: Questionnaires, Oncotype Dx Assay
19 Recruiting Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer
Conditions: Malignant Neoplasm of Breast;   Breast Cancer
Interventions: Drug: Genomically Directed Monotherapy;   Other: Observation/Standard Therapy
20 Not yet recruiting Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC)
Conditions: Triple-Negative Breast Neoplasms;   Breast Neoplasm;   Breast Cancer;   Triple-Negative Breast Cancer
Interventions: Drug: Trilaciclib;   Drug: Gemcitabine;   Drug: Carboplatin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.